Publication | Closed Access

Identification of novel class I and class IIb histone deacetylase inhibitor for Alzheimer's disease therapeutics

Alzheimer's DiseaseMedicineNeurochemical BiomarkersNovel ClassDisease TherapeuticsSystems BiologyPharmacologyDrug Discovery